Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Skin Melanoma”

533 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 533 results

Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Looking for participantsNCT05859074
What this trial is testing

MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Who this might be right for
Cutaneous Squamous Cell CarcinomaSCC - Squamous Cell CarcinomaBasal Cell Carcinoma+16 more
Memorial Sloan Kettering Cancer Center 56
Early research (Phase 1)Study completedNCT00625768
What this trial is testing

Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma

Who this might be right for
Metastatic Renal Cell CarcinomaMetastatic Malignant Melanoma
Antisoma Research 13
Early research (Phase 1)Study completedNCT00923169
What this trial is testing

Part 2 of Phase 1 Study of GC1008 to Treat Advanced Melanoma (Part 2 Will Only Accept and Treat Patients With Advanced Malignant Melanoma)

Who this might be right for
Renal Cell Carcinoma
National Cancer Institute (NCI) 9
Not applicableLooking for participantsNCT06643286
What this trial is testing

Evaluation of a Personalised Survivorship Care Plan App for Patients With Melanoma

Who this might be right for
Melanoma (Skin)Melanoma, Stage II, Stage IMelanoma Stage+1 more
Erasmus Medical Center 180
Early research (Phase 1)Ended earlyNCT01039844
What this trial is testing

Study of Weekly LOC-paclitaxel Injection for Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 37
Early research (Phase 1)Study completedNCT01703507
What this trial is testing

Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma

Who this might be right for
Recurrent MelanomaStage IV MelanomaTumors Metastatic to Brain
Sidney Kimmel Cancer Center at Thomas Jefferson University 17
Early research (Phase 1)Active Not RecruitingNCT05902520
What this trial is testing

Adoptive Cell Therapy Using Cancer Specific CD8+ Tumor Infiltrating Lymphocytes in Adult Patients With Solid Tumors

Who this might be right for
HNSCCMelanomaGynecologic Cancer+3 more
AgonOx, Inc. 18
Early research (Phase 1)Temporarily pausedNCT01841463
What this trial is testing

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Who this might be right for
Advanced or Inoperable Malignant Melanoma With BRAF Mutation
Piramal Enterprises Limited 100
Testing effectiveness (Phase 2)Study completedNCT02404441
What this trial is testing

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer+2 more
Novartis Pharmaceuticals 319
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Not applicableActive Not RecruitingNCT06549439
What this trial is testing

EFLASH for Skin Lesions of Malignant Melanomas

Who this might be right for
Metastatic Melanoma
University of Zurich 10
Early research (Phase 1)Study completedNCT00101270
What this trial is testing

Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas

Who this might be right for
Childhood Burkitt LymphomaChildhood Central Nervous System Germ Cell TumorChildhood Diffuse Large Cell Lymphoma+26 more
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT00515983
What this trial is testing

Vaccination of Melanoma Patients With Dendritic Cells Loaded With Allogeneic Apoptotic-Necrotic Melanoma Cells

Who this might be right for
Melanoma
José Mordoh, M.D., Ph.D. 16
Early research (Phase 1)WithdrawnNCT02447939
What this trial is testing

Pharmacokinetics of Repeat Oral Doses of Dabrafenib and the Combination of Dabrafenib and Trametinib in Chinese Subjects With Melanoma

Who this might be right for
Melanoma
GlaxoSmithKline
Testing effectiveness (Phase 2)Ended earlyNCT02706353
What this trial is testing

APX005M in Combination With Systemic Pembrolizumab in Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 34
Not applicableUnknownNCT03048253
What this trial is testing

A Phase I-c Study of Recombinant GM-CSF Herpes Simplex Virus to TreatⅣ M1c

Who this might be right for
Melanoma
OrienGene Biotechnology Ltd. 30
Testing effectiveness (Phase 2)Ended earlyNCT01350401
What this trial is testing

Phase I/II Study to Assess the Safety and Activity of Enhanced TCR Transduced Autologous T Cells in Metastatic Melanoma

Who this might be right for
Melanoma
Adaptimmune 4
Testing effectiveness (Phase 2)Study completedNCT01876212
What this trial is testing

Dendritic Cell Vaccines + Dasatinib for Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Walter J. Storkus 15
Testing effectiveness (Phase 2)Ended earlyNCT00924001
What this trial is testing

Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental
National Cancer Institute (NCI) 1
Load More Results